Chronic kidney disease is, above all, chronic — a condition a person lives with for years or decades, through many decisions and many transitions, while the rest of their life goes on. The preceding chapters treated the kidney; this capstone treats the journey and the person. Two ideas hold it together: that shared decision-making is a recurring practice rather than a single event, and that the patient is a whole person whose psychological, social, and spiritual life matters as much as their eGFR. The volume ends, as the last did, on the patient.
Shared decision-making as a through-line
Shared decision-making has appeared in chapter after chapter — in the frailty decisions, the modality choice, the timing of dialysis, the conservative-care option — and the capstone's first task is to name it as a single, recurring practice rather than a set of isolated conversations. Across the CKD journey there are repeated decision points: how aggressively to treat at diagnosis, which progression-slowing therapies to use and how hard, how to manage complications, which modality to prepare for, when and whether to start dialysis, whether to pursue transplantation, and how to approach goals of care. Each is approached with the same framework: establish and communicate the prognosis honestly, elicit the patient's values and goals, present the options without bias, deliberate together, document the decision and its reasoning, and revisit it as the illness and the patient's life evolve. The framework is the same; only the decision changes.
Effective care and the preference-sensitive decisions
The organising distinction of the whole volume — between effective care and preference-sensitive decisions — reaches its synthesis here. Effective care is what the evidence and physiology recommend, delivered regardless of preference: the progression-slowing pillars in the appropriate patient, the management of complications, honest prognostication, safe transitions, and never abandoning the patient. Preference-sensitive decisions are those that turn on the patient's values, and the volume has flagged many — the intensity of treatment in the frail, the choice of dialysis modality, the timing of dialysis, dialysis versus conservative management, the place of care and death. The clinician recommends the first and shares the second, and the discipline is to keep the line clear: not to offload an effective-care duty onto the patient as if it were a choice, and not to impose a default on a decision that is rightly theirs. Mapping these decisions, as the capstone does, is mapping where the patient's voice must govern.
The transitions of care
If the journey is long, it is also punctuated, and the punctuation marks — the transitions of care — are where patients are most often harmed. The CKD patient moves repeatedly: between primary care and nephrology in shared care; from paediatric to adult services; from CKD into kidney failure and onto dialysis, transplant, or conservative care; between modalities; from a failing transplant back to dialysis; between hospital and community; and from active management into conservative or end-of-life care. Each transition is a moment when information is lost, medications are reconciled badly or not at all, follow-up lapses, and the patient falls through a gap. The remedy is structural: deliberate, documented handover; continuity of the clinical narrative; and active communication between teams, rather than the assumption that the receiving team already knows the story. A transition managed as an event to be safeguarded, not a routine handoff, protects the patient at exactly the points where they are most exposed.
Two hard transitions
Two transitions deserve specific attention because they are both high-risk and emotionally laden. The first is the move from paediatric to adult services, which young adults navigate at a developmentally turbulent time, and which is associated with loss to follow-up, non-adherence, and — in transplant recipients — graft loss; structured transition programmes that prepare the young person and bridge the services reduce this harm. The second is graft failure returning a patient to dialysis, a transition that is clinically demanding — needing re-education, new access, the careful wind-down of immunosuppression, and re-listing where appropriate — and emotionally hard, because the patient is losing a transplant that may have given them years of freedom and grieving that loss while restarting a treatment they had escaped. Handled as a mere clinical event, it compounds the loss; handled as the difficult transition it is, with support alongside the logistics, it respects what the patient is going through.
The whole patient
Beyond decisions and transitions lies the person, and CKD touches the whole of them. The psychological burden is heavy and under-recognised: depression and anxiety are common in CKD and frequently go untreated, cognitive impairment is more prevalent than appreciated, and sexual dysfunction is rarely asked about. The symptom burden — fatigue, pain, poor sleep, low mood — rivals that of advanced cancer and is consistently under-treated. The social dimensions matter too: the effect on work and finances, the burden on caregivers, the disruption to family life. And the spiritual dimension is real for many patients facing a life-altering, life-shortening condition. Whole-person care attends to all of this — screening for and treating depression, asking about symptoms and sexual health, supporting the social and caregiver context, and respecting the patient's cultural and spiritual values — with the nephrologist as one member of a team caring for a life, not a kidney.
Self-management, continuity, and not fostering dependence
A whole-person, lifelong condition is best managed with the patient as an active participant, not a passive recipient. Self-management and patient activation — education, empowerment, and adherence support that equip the patient to manage their own condition — improve outcomes and put the patient at the centre, and they are a goal of care, not an optional extra. This is delivered through coordinated, continuous, multidisciplinary care, with the patient's own preferences and life as the organising principle. And there is a subtle balance here that the capstone should name: good chronic care supports the patient's capability and their other sources of support — family, community, primary care — rather than fostering over-reliance on the kidney service or any one clinician. The aim is a patient living their own life with CKD, supported but not dependent, with continuity ensuring no decision or transition is faced alone.
Where the evidence is firm, and where judgement and values govern
Some of this is firmly evidenced: shared decision-making improves the concordance of care with patients' values, self-management and patient activation improve outcomes, structured transition programmes reduce gaps, and the psychosocial burden of CKD is real and under-treated. Much of the rest — exactly how to weigh competing values, how to manage a particular transition, how to balance support against over-reliance — is judgement, because whole-person care over a lifelong illness cannot be reduced to a protocol. The honest close to the volume is that the science of the preceding chapters — the staging, the mechanisms, the pillars, the complication management — is fully deployed in the service of a human being making decisions about their own life. The kidney was the subject of seventeen chapters; the eighteenth, and the point of all of them, is the person.
